Publications by authors named "H Lena"

Claim this Profile
R
Real-World Use and Immunotherapy Rechallenge Outcomes with Nivolumab in Advanced Non-small Cell Lung Cancer in France: Interim Results of the LIST Study.
Benoît Godbert, Elisa Gobbini, Chantal Decroisette, Hervé Lena, Yaacoub Khalife

Oncol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of patients treated with ≥17 cycles of pembrolizumab monotherapy as first-line therapy and for previously treated advanced NSCLC: multicenter observational study in France.
Maurice Pérol, Clarisse Audigier-Valette, Hervé Léna, Marie-Ange Massiani, Xavier Quantin

Respir Med Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trial.
Guénaëlle Levallet, Christian Creveuil, Alexandre Léger-Vigot, Solenn Brosseau, Claire Danel

Transl Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis.
K Amrane, B Cabarrou, G Justeau, S Schneider, X Quantin, H Lena

ESMO Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Registered nurses' experiences of community-based nursing in a Swedish context.
Snogren Maria, Hagelberg Lena, Lideskar Annelie, Mårtensson Sophie

BMC Nurs· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis